Key result
Rare angiosarcoma develops around a hip prosthesis 14 years after total hip arthroplasty.
Why the study?
Angiosarcoma associated with hip joint prosthesis is extremely rare with few reported cases, and its clinical features and management remain unclear.
Population
1 patient with history of giant cell tumor and left total hip arthroplasty presenting with recurrent hematoma and angiosarcoma
Design
Case report
Follow-up
9 weeks after operation
Authors
Loading...
Rare late angiosarcoma after THA warrants long-term vigilance; leaves open prosthetic carcinogenicity for prospective cohort confirmation.
Case Report (n=1)
This case report highlights the rare occurrence of angiosarcoma secondary to a hip joint prosthesis, presenting as recurrent hematoma.
Zhu et al. (2016) conducted a case report in Angiosarcoma around hip joint prosthesis (n=1). Hip joint prosthesis was evaluated on Development of angiosarcoma. A male patient developed a rare angiosarcoma around a hip joint prosthesis 14 years after undergoing total hip arthroplasty for a giant cell tumor, eventually dying of respiratory failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: